홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
VSTM
#2622
Verastem, Inc.
5.7
2
+1.42%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+1.42%
월간 변동
-11.86%
6달 변화
-38.49%
년간 변동율
+6.32%
이전 종가
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
양
58
마켓
주식
헬스케어
VSTM
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
44.51 M
51.49 M
54.95 M
61.55 M
66.78 M
—
Valuation ratios
Enterprise value
19.9 M
177.37 M
213.77 M
91.09 M
451.93 M
934.16 M
Price to earnings ratio
—
-1.41
-1.79
-1.13
-2
-6.34
Price to sales ratio
8.03
18.46
14.85
63.8
36.92
134.03
Price to cash flow ratio
0.71
1.76
1.88
1.56
3.59
8.8
Price to book ratio
0.65
-6.39
-17.08
-7.89
-7.89
-39.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.19
0.64
0.4
0.13
0.56
1.72
Return on equity %
2.17
2.23
1.61
0.72
6.35
10.91
Return on invested capital %
1 018.92
1 043.91
2 007.91
967.24
602.43
4 621.49
Gross margin %
—
—
100
94.01
97.33
—
Operating margin %
—
—
2 419.17
2 047.92
362.17
—
EBITDA margin %
—
—
—
-2 027.09
-344.72
—
Net margin %
—
—
2 853.4
1 213.57
876.34
—
Liquidity ratios
Quick ratio
—
—
—
3.44
2.55
—
Current ratio
3.23
3.07
3.5
3.46
2.58
12.61
Inventory turnover
—
—
—
0.03
0.2
—
Asset turnover
0
0
0.02
0.01
0.06
0.09
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.4
0.54
0.38
0.44
1.76
Long term debt to total equity ratio
2.77
1.41
2.2
2.06
5.03
10.71
Per share metrics
Operating cash flow per share
0.59
0.7
0.71
0.44
0.5
2.35
EBIT per share
—
—
—
-0.59
-0.54
—
EBITDA per share
—
—
—
-0.59
-0.53
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.81
2.49
2.17
2.22
1.88
8.76
Net current asset value per share
3
2.66
2.3
2.35
2.11
9.42
Tangible book value per share
0.27
0.81
0.6
0.28
-0.02
1.67
Working capital per share
2.07
1.79
1.64
1.67
1.29
6.4
Book value per share
0.27
0.81
0.6
0.49
0.21
2.11
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
뉴스
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.라일리, Verastem 주식에 ’매수’ 등급 재확인, 목표가 16달러 유지
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
베라스템, 4분기 암 치료제 수익 1750만 달러 보고
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
애브비의 인수 가능성으로 레볼루션 메디신 주가 20% 이상 급등
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
베라스템, 미즈호 ’매수’ 등급 재확인에 주가 안정